Company Performance Metrics
Biofusion provides commercialise university intellectual property. In January 2005 Biofusion signed a 10 year exclusive agreement with the University of Sheffield to commercialise all the University owned medical IP.
Our partnership with a university works on the simple premise that all parties are more efficient and effective if they are able to
concentrate on their core skills – so the university focuses on creation, whilst Biofusion focuses on commercialisation. At the point of cross-over we ensure we are completely integrated into the university’s technology transfer processes, so that the take up and subsequent commercialisation is both seamless and painless.
As a shareholder in Biofusion the university is rewarded and incentivised to ensure that its vast R&D spend (over £500 million over the next 10 years in the case of Sheffield) is focused on generating world class IP, whilst the academics are rewarded with shareholdings in the subsequent portfolio companies.
Biofusion uses its start-up management skills and funds to commercialise this world class IP through licensing or spin-out companies.
